BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
219 hedge funds and large institutions have $1.53B invested in BioTelemetry, Inc. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 27 closing their positions.
30% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 27
17% more capital invested
Capital invested by funds: $1.31B → $1.53B (+$218M)
4% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 72
0% more funds holding
Funds holding: 219 → 219 (0)
54% less call options, than puts
Call options by funds: $4.78M | Put options by funds: $10.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$16M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$12M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$6.71M |
| 4 |
PM
Pembroke Management
Montreal,
Quebec, Canada
|
+$6.3M |
| 5 |
BlackRock
New York
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.48M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$3.16M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.53M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.53M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$2.19M |
BEAT Hedge Fund Activity: Q4 2019 in Review
219 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2019, worth a combined $1.53B — up 17% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new BEAT positions and 27 closed out — a net gain of 8 holders — while 75 added to existing stakes and 72 trimmed.
The largest buyer was Truist Financial, opening a new position worth an estimated $16M. The largest seller was Citadel Advisors, cutting an estimated $3.48M.
- 219 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $1.53B of BioTelemetry, Inc. stock for Q4 2019, up 17% quarter-over-quarter.
- 35 funds opened new BioTelemetry, Inc. positions in Q4 2019 and 27 closed out, a net change of +8 holders.
- The largest BioTelemetry, Inc. buyer in Q4 2019 was Truist Financial, an estimated $16M added.
- The largest BioTelemetry, Inc. seller in Q4 2019 was Citadel Advisors, an estimated $3.48M sold.
Based on aggregated 13F filings for Q4 2019.